SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-018183
Filing Date
2022-09-07
Accepted
2022-09-07 16:30:49
Documents
13
Period of Report
2022-09-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K alna-20220906.htm   iXBRL 8-K 60727
  Complete submission text file 0000950170-22-018183.txt   211989

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alna-20220906.xsd EX-101.SCH 2916
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alna-20220906_def.xml EX-101.DEF 13244
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alna-20220906_lab.xml EX-101.LAB 16621
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alna-20220906_pre.xml EX-101.PRE 12566
7 EXTRACTED XBRL INSTANCE DOCUMENT alna-20220906_htm.xml XML 6180
Mailing Address 142 -F NORTH ROAD, SUITE 150 SUDBURY MA 01776
Business Address 142 -F NORTH ROAD, SUITE 150 SUDBURY MA 01776 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 221231505
SIC: 2836 Biological Products, (No Diagnostic Substances)